Indoleamine-2,3-dioxygenase and Interleukin-6 associated with tumor response to neoadjuvant chemotherapy in breast cancer

PURPOSE: Indoleamine-2,3-dioxygenase (IDO) and Interleukin-6 (IL-6) contribute to poor therapeutic effects, tumor relapse and aggressive tumor growth. IDO and IL-6 incorporate a positive feedback signal loop to maintain IDO and IL-6 constitutive expression and facilitate tumor progression. RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Fangxuan, Wei, Lijuan, Li, Shixia, Liu, Juntian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746108/
https://www.ncbi.nlm.nih.gov/pubmed/29296206
http://dx.doi.org/10.18632/oncotarget.22253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746108/
https://www.ncbi.nlm.nih.gov/pubmed/29296206
http://dx.doi.org/10.18632/oncotarget.22253

Ejemplares similares